Exosome‐transmitted miR‐769‐5p confers cisplatin resistance and progression in gastric cancer by targeting CASP9 and promoting the ubiquitination degradation of p53

Human mesenchymal stem cells promote ischemic repairment and angiogenesis of diabetic foot through exosome miRNA-21-5p

(2021) Chen Huang et al.   Stem Cell Research

Exosomal transfer of miR-769-5p promotes osteosarcoma proliferation and metastasis by targeting DUSP16

(2021) Wanshun Liu et al.   Cancer Cell International

Caspase-11 promotes allergic airway inflammation

(2020) Zbigniew Zasłona et al.   Nature Communications

Targeting necroptosis in anticancer therapy: mechanisms and modulators

(2020) Ying Wu et al.   Acta Pharmaceutica Sinica B

Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance

(2020) Li Yuan et al.   Molecular Cancer

NEDD 4L‐mediated Merlin ubiquitination facilitates Hippo pathway activation

(2020) Yiju Wei et al.   EMBO REPORTS

Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer

(2020) Senlin Zhao et al.   Journal of Hematology & Oncology

Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance

(2019) Ladan Mashouri et al.   Molecular Cancer

Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer

(2019) In-Hye Ham et al.   Molecular Cancer

Exosomal miRNA-106b from cancer-associated fibroblast promotes gemcitabine resistance in pancreatic cancer

(2019) Yuan Fang et al.   EXPERIMENTAL CELL RESEARCH

MicroRNA-769-5p contributes to the proliferation, migration and invasion of hepatocellular carcinoma cells by attenuating RYBP

(2019) Yao Xian et al.   BIOMEDICINE & PHARMACOTHERAPY

MicroRNA-769-5p Promotes The Growth Of Glioma Cells By Targeting Lysine Methyltransferase 2A

(2019) Mingze Chang et al.   OncoTargets and Therapy

The PAX3-FOXO1 oncogene alters exosome miRNA content and leads to paracrine effects mediated by exosomal miR-486

(2019) Farah Ghamloush et al.   Scientific Reports

NEDD4 and NEDD4L regulate Wnt signalling and intestinal stem cell priming by degrading LGR5 receptor

(2019) Laura Novellasdemunt et al.   EMBO JOURNAL

Regulation of the Mdm2–p53 pathway by the ubiquitin E3 ligase MARCH7

(2018) Kailiang Zhao et al.   EMBO REPORTS

Exosomal miRNAs in hepatocellular carcinoma development and clinical responses

(2018) Shuangshuang Li et al.   Journal of Hematology & Oncology

A Quantitative Chemotherapy Genetic Interaction Map Reveals Factors Associated with PARP Inhibitor Resistance

(2018) Hsien-Ming Hu et al.   Cell Reports

Transfer of miRNA in Macrophage-Derived Exosomes Induces Drug Resistance in Pancreatic Adenocarcinoma

(2018) Yoav Binenbaum et al.   CANCER RESEARCH

Therapeutic Targeting Cancer-Initiating Cell Markers by Exosome miRNA: Efficacy and Functional Consequences Exemplified for claudin7 and EpCAM

(2018) Daisuke Kyuno et al.   Translational Oncology

Corrigendum: The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression

(2017) Efrat Shema et al.   GENES & DEVELOPMENT

Hypothalamic stem cells control ageing speed partly through exosomal miRNAs

(2017) Yalin Zhang et al.   NATURE

Unravelling the biology of SCLC: implications for therapy

(2017) Joshua K. Sabari et al.   Nature Reviews Clinical Oncology

Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA

(2016) Le Qu et al.   CANCER CELL

New insights and evolving role of pegylated liposomal doxorubicin in cancer therapy

(2016) Alberto A. Gabizon et al.   DRUG RESISTANCE UPDATES

miRNA Deregulation in Cancer Cells and the Tumor Microenvironment

(2016) R. Rupaimoole et al.   Cancer Discovery

Mechanisms of p53 degradation

(2015) Chuck C.-K. Chao   CLINICA CHIMICA ACTA

miRNA Isolation from FFPET Specimen: A Technical Comparison of miRNA and Total RNA Isolation Methods

(2015) Zsófia Brigitta Nagy et al.   PATHOLOGY & ONCOLOGY RESEARCH

p53 mutations in cancer

(2012) Patricia A. J. Muller et al.   NATURE CELL BIOLOGY

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Anoikis triggers Mdm2-dependent p53 degradation

(2010) Abhijit Ghosh et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Damage control: DNA repair, transcription, and the ubiquitin–proteasome system

(2009) Anne Daulny et al.   DNA REPAIR

Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation

(2009) Rosario Amato et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Ubiquitin Ligase Nedd4L Targets Activated Smad2/3 to Limit TGF-β Signaling

(2009) Sheng Gao et al.   MOLECULAR CELL

The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression

(2008) E. Shema et al.   GENES & DEVELOPMENT